Zydus Lifesciences Reports Q1 FY26 Financial Results: Revenue Up 6%, Net Profit Up 3%

Zydus Lifesciences Limited announced its unaudited consolidated financial results for the first quarter ended June 30, 2025. The company reported a 6% YoY increase in revenue from operations, which stood at Rs. 65,737 mn. Research & Development (R&D) investments for the quarter were Rs. 4,856 mn. EBITDA for the quarter was Rs. 20,885 mn, and net profit was Rs. 14,668 mn, up 3% YoY. Capex (organic) for the quarter was Rs. 4,020 mn. The company's business-wise sales performance showed a 5.8% YoY increase in the India Geography segment, and a 37% YoY increase in the International Markets segment. Zydus Lifesciences remains on track to achieve its FY2026 aspirations, with a focus on innovation, compliance, and global growth.